KURA ONCOLOGY INC (KURA) Stock Analyst Ratings
USA - NASDAQ:KURA - US50127T1097 - Common Stock
9.7 USD
+0.6 (+6.59%)
9.7 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 83% to KURA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 27.54. This target is 183.92% above the current price.
KURA was analyzed by 21 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about KURA.
In the previous month the buy percentage consensus was at a similar level.
KURA was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-20 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-10-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-04 | Guggenheim | Initiate | Neutral |
| 2025-08-11 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-06-26 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-06-20 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-06-04 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-05-19 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-05-02 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-29 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-04-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-06 | UBS | Maintains | Buy -> Buy |
| 2025-02-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-06 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-06 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-02-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-08 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2024-12-09 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-11-26 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-11-22 | B of A Securities | Maintains | Buy -> Buy |
| 2024-11-21 | TD Cowen | Reiterate | Buy |
| 2024-11-21 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-11-21 | Jefferies | Maintains | Buy -> Buy |
| 2024-11-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-19 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-11-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-06 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-11-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
KURA ONCOLOGY INC / KURA FAQ
What is the average price target for KURA ONCOLOGY INC (KURA) stock?
21 analysts have analysed KURA and the average price target is 27.54 USD. This implies a price increase of 183.92% is expected in the next year compared to the current price of 9.7.
Can you provide the consensus rating for KURA ONCOLOGY INC stock?
The consensus rating for KURA ONCOLOGY INC (KURA) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed KURA ONCOLOGY INC (KURA)?
The number of analysts covering KURA ONCOLOGY INC (KURA) is 21.